BioXcel Therapeutics CEO Vimal Mehta's 2019 pay jumps 181% to $2M
BioXcel Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 6, 2020
BioXcel Therapeutics reported fiscal year 2019 executive compensation information on April 6, 2020.
In 2019, three executives at BioXcel Therapeutics received on average a compensation package of $961K, a 43% increase compared to previous year.
Average pay of disclosed executives at BioXcel Therapeutics
Vimal Mehta, Chief Executive Officer, received $2M in total, which increased by 181% compared to 2018. 64% of Mehta's compensation, or $1.3M, was in option awards. Mehta also received $233K in non-equity incentive plan, $459K in salary, as well as $7.8K in other compensation.
Vincent O'Neill, Chief Medical Officer, received a compensation package of $510K, which decreased by 23% compared to previous year. 80% of the compensation package, or $406K, was in salary.
Richard Steinhart, Chief Financial Officer, earned $404K in 2019.
Related executives
You may also like
Source: SEC filing on April 6, 2020.